Glimepiride, Metformin SR, and Pioglitazone''"''""'"

Glimepiride, Metformin SR, and Pioglitazone
SEIZMET GP are medications commonly used in the management of type 2 diabetes. They belong to different classes of antidiabetic drugs and are often prescribed in combination to achieve better glycemic control. Here's a brief overview of each medication: Glimepiride is a sulfonylurea, which is a class of oral antidiabetic drugs. It stimulates the release of insulin from the pancreas, helping to lower blood sugar levels. Indications: Glimepiride is used to treat type 2 diabetes. Metformin SR (Sustained Release): Metformin is a biguanide, another class of oral antidiabetic drugs. Metformin primarily works by reducing the production of glucose by the liver and improving insulin sensitivity in the body's tissues, leading to better glucose utilization. Metformin is commonly used to treat type 2 diabetes. The sustained-release (SR) formulation provides a gradual release of the medication over time. Pioglitazone is a thiazolidinedione (TZD) or glitazone. Mechanism of Action: It improves insulin sensitivity in peripheral tissues, such as muscles and adipose tissue. Pioglitazone also reduces glucose production in the liver. Pioglitazone is used to improve glycemic control in individuals with type 2 diabetes. For further information please contact: info@sterispharma.com Order Now - https://www.sterisonline.com/product/seizmet-gp-2-133443